Abstract
Background: The safety of zopiclone and other Z-drug use has been questioned in many regards. Past issues of side effects, tolerance, abuse, addition, and inappropriate uses have all deserved attention.
Objective: In this paper, the issue of zopiclone safety is again reviewed for information newly arising over the last decade. Method: Information databases were scanned for ‘zopiclone’, and all relevant literature was reviewed. Results: Zopiclone continues to be a very frequently consumed sedative-hypnotic. It is often found in the blood of those with drug abuse, self-harm, overdose, and road accidents. The drug is flourishing as a medication for the elderly, and numerous adverse consequences, including injury, have been associated with it. Zopiclone impairs driving ability, and methods to determine such impairment among active drivers are needed. Conclusion: We have previously suggested that zopiclone prescription and use should have the same concerns as those for benzodiazepine pharmacotherapy. There is evidently no need to change such a stance.Keywords: Zopiclone, risk, safety, side-effects, withdrawal, addiction.
Graphical Abstract
Current Psychopharmacology
Title:Safety with Zopiclone Use: Contemporary Issues
Volume: 6
Author(s): Nevio Cimolai*
Affiliation:
- Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver,Canada
Keywords: Zopiclone, risk, safety, side-effects, withdrawal, addiction.
Abstract: Background: The safety of zopiclone and other Z-drug use has been questioned in many regards. Past issues of side effects, tolerance, abuse, addition, and inappropriate uses have all deserved attention.
Objective: In this paper, the issue of zopiclone safety is again reviewed for information newly arising over the last decade. Method: Information databases were scanned for ‘zopiclone’, and all relevant literature was reviewed. Results: Zopiclone continues to be a very frequently consumed sedative-hypnotic. It is often found in the blood of those with drug abuse, self-harm, overdose, and road accidents. The drug is flourishing as a medication for the elderly, and numerous adverse consequences, including injury, have been associated with it. Zopiclone impairs driving ability, and methods to determine such impairment among active drivers are needed. Conclusion: We have previously suggested that zopiclone prescription and use should have the same concerns as those for benzodiazepine pharmacotherapy. There is evidently no need to change such a stance.Export Options
About this article
Cite this article as:
Cimolai Nevio*, Safety with Zopiclone Use: Contemporary Issues, Current Psychopharmacology 2017; 6 (1) . https://dx.doi.org/10.2174/2211556005666160822112843
DOI https://dx.doi.org/10.2174/2211556005666160822112843 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of G-Protein-Coupled Receptor Signalling by the Scaffolding Proteins Spinophilin/Neurabin 2 and Neurabin 1
Current Chemical Biology Stemness or Not Stemness? Current Status and Perspectives of Adult Retinal Stem Cells
Current Stem Cell Research & Therapy Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2
Current Drug Metabolism Simultaneous Determination of Total Cortisol and Cortisone in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry: Method Development, Validation and Preliminary Clinical Application
Current Pharmaceutical Analysis Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Formulation and Evaluation of Solid Lipid Nanoparticles of Quetiapine Fumarate and Quetiapine Hemifumarate for Brain Delivery in Rat Model
Pharmaceutical Nanotechnology Hymenoptera Venom Proteins and Peptides for Diagnosis and Treatment of Venom Allergic Patients
Inflammation & Allergy - Drug Targets (Discontinued) Biomarkers of Senescence during Aging as Possible Warnings to Use Preventive Measures
Current Medicinal Chemistry Indole Alkaloids and Semisynthetic Indole Derivatives as Multifunctional Scaffolds Aiming the Inhibition of Enzymes Related to Neurodegenerative Diseases – A Focus on Psychotria L. Genus
Current Topics in Medicinal Chemistry Targeting ErbB Receptors in High-Grade Glioma
Current Pharmaceutical Design Review of Treatment for Cocaine Dependence
Current Drug Abuse Reviews An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases
Mini-Reviews in Medicinal Chemistry Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry How and When Environmental Agents and Dietary Factors Affect the Course of Alzheimers Disease: The “LEARn” Model (Latent Early-Life Associated Regulation) May Explain the Triggering of AD
Current Alzheimer Research Assessment of Possible Drug Interactions in Patients with Psoriasis and Associated Comorbid Medical Conditions: An Observational Study
Reviews on Recent Clinical Trials Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics
Medicinal Chemistry The Self-Reference Effect on Episodic Memory Recollection in Young and Older Adults and Alzheimer’s Disease
Current Alzheimer Research Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?
CNS & Neurological Disorders - Drug Targets Cerebral Artery Vasoconstriction is Endothelin-1 Dependent Requiring Neurogenic and Adrenergic Crosstalk
Current Neurovascular Research Exploring 1,3,4-Oxadiazole Scaffold for Anti-inflammatory and Analgesic Activities: A Review of Literature From 2005-2016
Mini-Reviews in Medicinal Chemistry